סך נכסים נקיים: twistbioscience.com (TWST)

This chart illustrates the price action of Twist Bioscience (TWST), where the key metric stands at 0.47. The business relies on a large-scale US plant utilizing silicon platforms for the mass synthesis of nucleic acids. Growth is accelerating through partnerships with IT behemoths in the data storage sector, while the method's sustainability minimizes the use of plastics and reagents.

Book value capitalization determines the intrinsic value of a business by subtracting all liabilities from total assets. This metric reflects net equity, allowing the size of balance sheet equity to promptly capture value erosion prior to the publication of financial statements. A decline in this metric signals risks, whereas growth confirms financial stability. For Twist Bioscience (TWST), this is critical when scaling DNA synthesizers. Expanding capacity requires significant investments, which impact capital dynamics.